Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study. (2016)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hep.28359

PubMed Identifier: 26597786

Publication URI: http://europepmc.org/abstract/MED/26597786

Type: Journal Article/Review

Volume: 64

Parent Publication: Hepatology (Baltimore, Md.)

Issue: 1

ISSN: 0270-9139